Aerpio Pharmaceuticals

Aerpio Reports Second Quarter 2017 Financial Results

August 14th, 2017

Continue to Dose Patients in the TIME-2b Clinical Trial of AKB-9778 in Patients with Diabetic Retinopathy

Read the press release.